Prenetics develops and markets the IM8 line of science-backed premium supplements for daily nutrition and longevity, which has scaled rapidly through direct-to-consumer sales and high-profile partnerships. It additionally provides CircleDNA genetic testing services delivering personalized wellness reports based on advanced sequencing. The business focuses on consumer health products grounded in scientific research and global distribution.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 12 | — | -12.4 | — |
| Q3 2025 | 23.6 | — | -7.4 | — |
| Q4 2025 | 36.6 | — | -7.5 | — |
| Q1 2026 | 36 | — | -23.1 | — |
| Q2 2026 | 46.5 | 288.6% | -9 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Viemed Healthcare, Inc. (VMD), Perion Network Ltd. (PERI), Editas Medicine, Inc. (EDIT), Vital Farms, Inc. (VITL), Kochav Defense Acquisition Corp. (KCHV), ProCap Financial Inc (BRR)